Age at diagnosis of Type 2 diabetes in Germany: a nationwide analysis based on claims data from 69 million people.
Journal
Diabetic medicine : a journal of the British Diabetic Association
ISSN: 1464-5491
Titre abrégé: Diabet Med
Pays: England
ID NLM: 8500858
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
accepted:
05
08
2019
pubmed:
8
8
2019
medline:
3
11
2021
entrez:
8
8
2019
Statut:
ppublish
Résumé
For many European countries, including Germany, no valid estimates are available on age at diagnosis of Type 2 diabetes. Thus, we aimed to estimate the age at diagnosis in Germany. Age at diagnosis of Type 2 diabetes in Germany was estimated based on Type 2 diabetes prevalence and incidence and the age distribution of the German population. Age- and sex-specific incidence and prevalence in 2014/2015, based on claims data from statutory health insurance (n= 69 000 000, ~85% of the German population), and the age pyramid for Germany in 2015 were used for the calculation. Age at Type 2 diabetes diagnosis was stratified by sex. CIs were estimated using bootstrap methods. In addition, the age range in which 50% of the population received a diagnosis of Type 2 diabetes was calculated (the interquartile range). The mean ± sd age at Type 2 diabetes diagnosis in 2015 was 61.0 ± 13.4 years (95% CI 60.9-61.0) in men. Women were diagnosed ~2 years later than men (mean age 63.4 ± 14.9 years; 95% CI 63.4-63.5). The age range in which 50% of the population was diagnosed with diabetes was 53-72 years for men and 54-76 years for women. The sex differences are mainly attributable to a higher incidence of Type 2 diabetes in men than women during middle age and the higher absolute number of women in the older ages. The early age at diabetes diagnosis compared to average life expectancy means that the risk of diabetes-related complications is increased.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1723-1727Informations de copyright
© 2019 Diabetes UK.
Références
Brinks R, Landwehr S, Waldeyer R. Age of onset in chronic diseases: new method and application to dementia in Germany. Popul Health Metr 2013; 11: 6.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018; 138: 271-281.
Tönnies T, Rockl S, Hoyer A, Heidemann C, Baumert J, Du Y et al. Projected number of people with diagnosed Type 2 diabetes in Germany in 2040. Diabet Med 2019; 36: 1217-1225. https://doi.org/10.1111/dme.13902 [Epub ahead of print].
Du Y, Heidemann C, Schaffrath Rosario A, Buttery A, Paprott R, Neuhauser H et al. Changes in diabetes care indicators: findings from German National Health Interview and Examination Surveys 1997-1999 and 2008-2011. BMJ Open Diabetes Res Care 2015; 3: e000135.
Awa WL, Fach E, Krakow D, Welp R, Kunder J, Voll A et al. Type 2 diabetes from pediatric to geriatric age: analysis of gender and obesity among 120,183 patients from the German/Austrian DPV database. Eur J Endocrinol 2012; 167: 245-254.
Goffrier B, Schulz M, Bätzing-Feigenbaum J. Administrative Prävalenzen und Inzidenzen des Diabetes mellitus von 2009 bis 2015. Versorgungsatlas-Bericht Nr 17/03. 2017;https://doi.org/10.20364/va-17.03.
Federal Statistical Office. Population in Germany 2015 based on census 2011, [Cited: 2019 June 04]. https://service.destatis.de/bevoelkerungspyramide/index.html#!y=2015&v=22015.
Tamayo T, Brinks R, Hoyer A, Kuss OS, Rathmann W. The Prevalence and Incidence of Diabetes in Germany. Dtsch Arztebl Int 2016; 113: 177-182.
Heidemann C, Du Y, Paprott R, Haftenberger M, Rathmann W, Scheidt-Nave C. Temporal changes in the prevalence of diagnosed diabetes, undiagnosed diabetes and prediabetes: findings from the German Health Interview and Examination Surveys in 1997-1999 and 2008-2011. Diabet Med 2016; 33: 1406-1414.
Huo L, Magliano DJ, Rancière F, Harding JL, Nanayakkara N, Shaw JE et al. Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997-2011. Diabetologia 2018; 61: 1055-1063.
Guðbjörnsdóttir S, Eliasson B, Cederholm J, Zethelius B, Svensson A-M, Samuelsson P. Swedish National Diabetes Register, Annual report 2013. Centre of Registers, Västra Götaland, 2014. Available at https://www.ndr.nu/pdfs/Annual_Report_NDR_2013.pdf. Last accessed 4 July 2019.
Farmer RE, Ford D, Mathur R, Chaturvedi N, Kaplan R, Smeeth L et al. Metformin use and risk of cancer in patients with type 2 diabetes: a cohort study of primary care records using inverse probability weighting of marginal structural models. Int J Epidemiol 2019; https://doi.org/10.1093/ije/dyz005 [Epub ahead of print].
International Diabetes Federation. IDF Diabetes Atlas 8th Edition, 2017. Available at https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/134-idf-diabetes-atlas-8th-edition.html. Last accessed 4 June 2019.
Andersson T, Ahlbom A, Carlsson S. Diabetes Prevalence in Sweden at Present and Projections for Year 2050. PloS One 2015; 10:e0143084-e.
Sharma M, Nazareth I, Petersen I. Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study. BMJ Open 2016; 6(1): e010210.
Statista. European Union: Age distribution in member states in 2017 [Europäische Union: Altersstruktur in den Mitgliedsstaaten im Jahr 2017], 2019. Available at https://de.statista.com. Accessed 4 June 2019.
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736-1788.
Paprott R, Mensink GBM, Schulze MB, Thiele S, Muhlenbruch K, Scheidt-Nave C et al. Temporal changes in predicted risk of type 2 diabetes in Germany: findings from the German Health Interview and Examination Surveys 1997-1999 and 2008-2011. BMJ Open 2017; 7: e013058.